Literature DB >> 26515679

Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection.

Molebogeng X Rangaka1, Solange C Cavalcante2, Ben J Marais3, Sok Thim4, Neil A Martinson5, Soumya Swaminathan6, Richard E Chaisson7.   

Abstract

The billions of people with latent tuberculosis infection serve as the seedbeds for future cases of active tuberculosis. Virtually all episodes of tuberculosis disease are preceded by a period of asymptomatic Mycobacterium tuberculosis infection; therefore, identifying infected individuals most likely to progress to disease and treating such subclinical infections to prevent future disease provides a crucial opportunity to interrupt tuberculosis transmission and reduce the global burden of tuberculosis disease. Programmes focusing on single strategies rather than comprehensive programmes that deliver an integrated arsenal for tuberculosis control might continue to struggle. Tuberculosis preventive therapy is a poorly used method that is essential for controlling the reservoirs of disease that drive the epidemic. Comprehensive control strategies that combine preventive therapy for the most high-risk populations and communities with improved case-finding and treatment, control of transmission, and health systems strengthening could ultimately lead to worldwide tuberculosis elimination. In this Series paper we outline challenges to implementation of preventive therapy and provide pragmatic suggestions for overcoming them. We further advocate for tuberculosis preventive therapy as the core of a renewed worldwide focus to implement a comprehensive epidemic control strategy that would reduce new tuberculosis cases to elimination targets. This strategy would be underpinned by accelerated research to further understand the biology of subclinical tuberculosis infections, develop novel diagnostics and drug regimens specifically for subclinical tuberculosis infection, strengthen health systems and community engagement, and enhance sustainable large scale implementation of preventive therapy programmes.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26515679      PMCID: PMC4684745          DOI: 10.1016/S0140-6736(15)00323-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  54 in total

1.  The effect of antimicrobial therapy on the prognosis of primary tuberculosis in children.

Authors:  E M LINCOLN
Journal:  Am Rev Tuberc       Date:  1954-05

2.  Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model.

Authors:  David W Dowdy; Jonathan E Golub; Valeria Saraceni; Lawrence H Moulton; Solange C Cavalcante; Silvia Cohn; Antonio G Pacheco; Richard E Chaisson; Betina Durovni
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-15       Impact factor: 3.731

Review 3.  Latent Mycobacterium tuberculosis infection.

Authors:  Haileyesus Getahun; Alberto Matteelli; Richard E Chaisson; Mario Raviglione
Journal:  N Engl J Med       Date:  2015-05-28       Impact factor: 91.245

Review 4.  Controlled chemoprophylaxis trials in tuberculosis. A general review.

Authors:  S H Ferebee
Journal:  Bibl Tuberc       Date:  1970

Review 5.  Isoniazid for preventing tuberculosis in non-HIV infected persons.

Authors:  M J Smieja; C A Marchetti; D J Cook; F M Smaill
Journal:  Cochrane Database Syst Rev       Date:  2000

6.  A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

Authors:  Christine Danel; Raoul Moh; Delphine Gabillard; Anani Badje; Jérôme Le Carrou; Timothée Ouassa; Eric Ouattara; Amani Anzian; Jean-Baptiste Ntakpé; Albert Minga; Gérard M Kouame; Franck Bouhoussou; Arlette Emieme; Antoine Kouamé; André Inwoley; Thomas-d'Aquin Toni; Hugues Ahiboh; Mathieu Kabran; Cyprien Rabe; Baba Sidibé; Gustave Nzunetu; Romuald Konan; Joachim Gnokoro; Patrice Gouesse; Eugène Messou; Lambert Dohoun; Synali Kamagate; Abo Yao; Solange Amon; Amadou-Barenson Kouame; Aboli Koua; Emmanuel Kouamé; Yao Ndri; Olivier Ba-Gomis; Marcelle Daligou; Simplice Ackoundzé; Denise Hawerlander; Alex Ani; Fassery Dembélé; Fatoumata Koné; Calixte Guéhi; Constance Kanga; Serge Koule; Jonas Séri; Mykayila Oyebi; Nathalie Mbakop; Olewole Makaila; Carole Babatunde; Nathanael Babatounde; Gisèle Bleoué; Mireille Tchoutedjem; Alain-Claude Kouadio; Ghislaine Sena; Sahinou-Yediga Yededji; Rodrigue Assi; Alima Bakayoko; Alassane Mahassadi; Alain Attia; Armel Oussou; Max Mobio; Doféré Bamba; Mesmin Koman; Apollinaire Horo; Nina Deschamps; Henri Chenal; Madeleine Sassan-Morokro; Seidou Konate; Kakou Aka; Eba Aoussi; Valérie Journot; Célestin Nchot; Sophie Karcher; Marie-Laure Chaix; Christine Rouzioux; Papa-Salif Sow; Christian Perronne; Pierre-Marie Girard; Hervé Menan; Emmanuel Bissagnene; Auguste Kadio; Virginie Ettiegne-Traore; Corinne Moh-Semdé; Abo Kouame; Jean-Marie Massumbuko; Geneviève Chêne; Mireille Dosso; Serge K Domoua; Thérèse N'Dri-Yoman; Roger Salamon; Serge P Eholié; Xavier Anglaret
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

7.  Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection.

Authors:  A M Mandalakas; H L Kirchner; C Lombard; G Walzl; H M S Grewal; R P Gie; A C Hesseling
Journal:  Int J Tuberc Lung Dis       Date:  2012-06-11       Impact factor: 2.373

8.  Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies.

Authors:  G W Comstock; C Baum; D E Snider
Journal:  Am Rev Respir Dis       Date:  1979-05

9.  Eliminating tuberculosis one neighborhood at a time.

Authors:  J Peter Cegielski; David E Griffith; Paul K McGaha; Melanie Wolfgang; Celia B Robinson; Patricia A Clark; Willis L Hassell; Valerie A Robison; Kerfoot P Walker; Charles Wallace
Journal:  Am J Public Health       Date:  2012-10-18       Impact factor: 9.308

Review 10.  The immunological life cycle of tuberculosis.

Authors:  Joel D Ernst
Journal:  Nat Rev Immunol       Date:  2012-07-13       Impact factor: 53.106

View more
  53 in total

1.  Contact Investigation: A Priority for Tuberculosis Control Programs.

Authors:  Matthew J Saunders; Sumona Datta
Journal:  Am J Respir Crit Care Med       Date:  2016-11-01       Impact factor: 21.405

Review 2.  Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade.

Authors:  Danielle Cazabon; Hannah Alsdurf; Srinath Satyanarayana; Ruvandhi Nathavitharana; Ramnath Subbaraman; Amrita Daftary; Madhukar Pai
Journal:  Int J Infect Dis       Date:  2016-10-26       Impact factor: 3.623

Review 3.  Treatment of Latent Tuberculosis Infection-An Update.

Authors:  Moises A Huaman; Timothy R Sterling
Journal:  Clin Chest Med       Date:  2019-12       Impact factor: 2.878

Review 4.  Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis.

Authors:  Helen E Jenkins; Courtney M Yuen; Carly A Rodriguez; Ruvandhi R Nathavitharana; Megan M McLaughlin; Peter Donald; Ben J Marais; Mercedes C Becerra
Journal:  Lancet Infect Dis       Date:  2016-12-08       Impact factor: 25.071

Review 5.  HIV and tuberculosis in prisons in sub-Saharan Africa.

Authors:  Lilanganee Telisinghe; Salome Charalambous; Stephanie M Topp; Michael E Herce; Christopher J Hoffmann; Peter Barron; Erik J Schouten; Andreas Jahn; Rony Zachariah; Anthony D Harries; Chris Beyrer; Joseph J Amon
Journal:  Lancet       Date:  2016-07-14       Impact factor: 79.321

6.  Structural barriers to implementing recommended tuberculosis preventive treatment in primary care clinics in rural South Africa.

Authors:  Divya K Chandra; Anthony P Moll; Frederick L Altice; Elizabeth Didomizio; Laurie Andrews; Sheela V Shenoi
Journal:  Glob Public Health       Date:  2021-03-02

7.  Implementation of isoniazid preventive therapy in southern Lima, Peru: an analysis of health center characteristics.

Authors:  Roberto Zegarra-Chapoñan; Lily Victoria Bonadonna; Courtney M Yuen; Martha Brigida Martina-Chávez; Jhon Zeladita-Huaman
Journal:  Infect Dis Poverty       Date:  2021-05-07       Impact factor: 4.520

8.  Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.

Authors:  Salmaan Keshavjee; Farhana Amanullah; Adithya Cattamanchi; Richard Chaisson; Karen M Dobos; Gregory J Fox; Howard E Gendelman; Richard Gordon; Anneke Hesseling; Hoi Le Van; Beate Kampmann; Bavesh Kana; Gopal Khuller; David M Lewinsohn; Deborah A Lewinsohn; Philiana Ling Lin; Lenette Lin Lu; Gary Maartens; Andrew Owen; Marina Protopopova; Jyothi Rengarajan; Eric Rubin; Padmini Salgame; Erwin Schurr; James A Seddon; Susan Swindells; David M Tobin; Zarir Udwadia; Gerhard Walzl; Sudha Srinivasan; Roxana Rustomjee; Payam Nahid
Journal:  Am J Respir Crit Care Med       Date:  2019-03-01       Impact factor: 21.405

9.  TB prevention cascade at a district hospital in rural Eastern Cape, South Africa.

Authors:  B J van de Water; T N Meyer; M Wilson; C Young; B Gaunt; K W le Roux
Journal:  Public Health Action       Date:  2021-06-21

10.  Upregulation of PD-1 expression on circulating CD8+ but not CD4+ T cells is associated with tuberculosis infection in health care workers.

Authors:  Cui-Lin Shi; Jian-Ping Zhang; Ping Xu; Jin Li; Jie Shen; Mei-Ying Wu; Zhi-Jian Ye; Xin Yu; Hua-Feng Song; Hui Chen; Jun-Chi Xu; Yu Pang; Jian-An Huang
Journal:  BMC Immunol       Date:  2021-06-25       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.